Venture capital firm based in London, UK
Cytospire Therapeutics raises £61m to advance pan-gamma delta T cell first-in-human trials. Read more
Edinburgh based Trogenix raises £70m led by IQ Capital with 4BIO Capital. Trogenix's Odysseus platform combines targeted cancer cell killing and immune stimulation to deliver precise, potentially curative therapies. Read more
ViaNautis secures $25 million in funding to revolutionize nanomedicine with their groundbreaking PolyNaut® platform, bringing advanced medical treatments closer to reality. Read more
| Biotech | 66.7% |
| Healthtech | 33.3% |